ArticleCancer research2013

Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance.

Melissa M Berrien-Elliott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.